In late November Abbott—one of Dexcom’s main competitors— recalled some of its CGMs due to inaccurate low glucose readings.
Young and the Invested on MSN

7 best growth stocks to buy for 2026

Growth stocks are still on the menu for 2026. The first few months of 2025 were a roller-coaster ride that threatened to ...